Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-25-023976)

Filing Details

Accession Number:: 0001140361-25-023976
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-06-27 16:27:23
Reporting Period:: 2025-06-27

Filing Date:: 2025-06-27
Accepted Time:: 2025-06-27 16:27:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
275053	Natures Sunshine Products Inc	NATR	Pharmaceutical Preparations (2834)	870327982

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1615258	Shanghai Fosun Pharmaceutical (Group) Co., Ltd.	Building A, No. 1289 Yishan Road Shanghai F4 200233		No	No	No	No
2071437	Fosun Pharma Usa Inc.	104 Carnegie Center Drive Suite 204 Princeton NJ 08540		No	No	No	No

Transaction Summary

Sold:	2,854,607 shares	Avg. Price: $11.46	Total Value: $32,713,796.22

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-06-27	2,854,607	$11.46	0	No	4	S	Indirect	by Fosun Pharma USA Inc.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	by Fosun Pharma USA Inc.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	64,167	Indirect	by Fosun Industrial Co., Limited

Footnotes

The shares were sold pursuant to that certain Underwriting Agreement. dated June 25, 2025, among Fosun Pharma USA Inc., the Issuer, and the underwriter party thereto.
Fosun Pharma USA Inc. is a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Fosun Industrial Co., Limited is a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.